| Today, Tue, Feb 9, 2010 |
| |
Becton Recalls Catheters Zacks.com (Tue 3:49pm)
|
| |
Health Care: Rx for MBA Job Blues BusinessWeek (Tue 8:08am)
|
| Mon, Feb 8, 2010 |
| |
CORRECTED - EU expected to clear Abbott, Solvay deal - sources at Reuters (Mon 2:58pm)
|
| |
Traders Send Select Stem Cell Shares Soaring Indie Research (Mon 10:28am)
|
| |
Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval PRNewswire (Mon 9:30am)
|
| Fri, Feb 5, 2010 |
| |
[video] CNBC.com Market Outlook at CNBC (Fri, Feb 5)
|
| |
Four Cheap Stocks with Solid Earnings Morningstar.com (Fri, Feb 5)
|
| Thu, Feb 4, 2010 |
| |
Allergan's Looking Real Pretty Right Now at CNBC (Thu, Feb 4)
|
| |
Test of "artificial pancreas" offers diabetes hope at Reuters (Thu, Feb 4)
|
| |
Two Pharmas at Forbes.com (Thu, Feb 4)
|
| |
Buy These 4 High-Quality Large Caps: Chief Investor at CNBC (Thu, Feb 4)
|
| |
4-Star Stocks Poised to Pop: Myriad Genetics at Motley Fool (Thu, Feb 4)
|
| |
3 Simple Keys to Dividend Investing at Seeking Alpha (Thu, Feb 4)
|
| Wed, Feb 3, 2010 |
| |
Ten Questions About High Cholesterol at Forbes.com (Wed, Feb 3)
|
| |
Pfizer's Hedge Pays Off at Motley Fool (Wed, Feb 3)
|
| |
Acquisitions In Home Health Care And Medical Diagnostics Sector Will Rise In 2010 According To RBC Capital Markets Expert Equity Analyst: Strong Cash Flow And Personalized Medicine Are Drivers Wall Street Transcript (Wed, Feb 3)
|
| Tue, Feb 2, 2010 |
| |
Ten Misleading Drug Ads at Forbes.com (Tue, Feb 2)
|
| |
Former Wyeth CEO: Pharma Chiefs Face 'More Punishing' Environment at The Wall Street Journal Online (Tue, Feb 2)
|
| |
Defense! Defense! at Motley Fool (Tue, Feb 2)
|
| |
Shaking Up the Biotech Industry at Motley Fool (Tue, Feb 2)
|
| Older Headlines |
|
|
|
|